Abstract
To describe baseline neurologic function of symptomatic patients in an international registry for transthyretin amyloidosis (ATTR). The Transthyretin Amyloidosis Outcomes Survey (THAOS) characterizes the natural history of ATTR, regional differences in disease expression, and genotypic-phenotypic relationships. Eligible patients have confirmed genotyped TTR mutations with or without symptomatic disease, or wild-type ATTR. Recommended minimal neurologic evaluations include pinprick, touch, and vibration of the great toe; ankle and patellar reflexes; muscle strength of toes and ankles.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
